Predictors of Mortality in Critically Ill COVID‐19 Patients Demanding High Oxygen Flow: A Thin Line between Inflammation, Cytokine Storm, and Coagulopathy
Authors:
- Slobodan KlasnjaSKSlobodan Klasnja
- Natasa MilicNatasa Milic
- Nina RajovicNRNina Rajovic
- Aleksandra AleksicAAAleksandra Aleksic
- Marija MilenkovicMMMarija Milenkovic
- Bogdan CrnokrakBCBogdan Crnokrak
- Bela BalintBBBela Balint
- Milena Todorovic-BalintMTMilena Todorovic-Balint
- Davor MrdaDMDavor Mrda
- Darko ZdravkovicDZDarko Zdravkovic
- Borislav ToskovicBTBorislav Toskovic
Open Access
- 1 January 2021
- journal article
- research article
- Published by Wiley in Oxidative Medicine and Cellular Longevity
- Vol. 2021 (1)
Abstract
Introduction. Mortality among critically ill COVID‐19 patients remains relatively high despite different potential therapeutic modalities being introduced recently. The treatment of critically ill patients is a challenging task, without identified credible predictors of mortality. Methods. We performed an analysis of 160 consecutive patients with confirmed COVID‐19 infection admitted to the Respiratory Intensive Care Unit between June 23, 2020, and October 2, 2020, in University Hospital Center Bezanijska kosa, Belgrade, Serbia. Patients on invasive, noninvasive ventilation and high flow oxygen therapy with moderate to severe ARDS, according to the Berlin definition of ARDS, were selected for the study. Demographic data, past medical history, laboratory values, and CT severity score were analyzed to identify predictors of mortality. Univariate and multivariate logistic regression models were used to assess potential predictors of mortality in critically ill COVID‐19 patients. Results. The mean patient age was 65.6 years (range, 29–92 years), predominantly men, 68.8%. 107 (66.9%) patients were on invasive mechanical ventilation, 31 (19.3%) on noninvasive, and 22 (13.8%) on high flow oxygen therapy machine. The median total number of ICU days was 10 (25th to 75th percentile: 6–18), while the median total number of hospital stay was 18 (25th to 75th percentile: 12–28). The mortality rate was 60% (96/160). Univariate logistic regression analysis confirmed the significance of age, CRP, and lymphocytes at admission to hospital, serum albumin, D‐dimer, and IL‐6 at admission to ICU, and CT score. Serum albumin, D‐dimer, and IL‐6 at admission to ICU were independently associated with mortality in the final multivariate analysis. Conclusion. In the present study of 160 consecutive critically ill COVID‐19 patients with moderate to severe ARDS, IL‐6, serum albumin, and D‐dimer at admission to ICU, accompanied by chest CT severity score, were marked as independent predictors of mortality.Keywords
This publication has 52 references indexed in Scilit:
- The pivotal link between ACE2 deficiency and SARS-CoV-2 infectionEuropean Journal of Internal Medicine, 2020
- D‐dimer levels on admission to predict in‐hospital mortality in patients with Covid‐19Journal of Thrombosis and Haemostasis, 2020
- Central nervous system manifestations of COVID-19: A systematic reviewJournal of the Neurological Sciences, 2020
- Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysisClinical Chemistry and Laboratory Medicine (CCLM), 2020
- Gastrointestinal and liver manifestations in patients with COVID-19Journal of the Chinese Medical Association, 2020
- Chest CT Severity Score: An Imaging Tool for Assessing Severe COVID-19Radiology: Cardiothoracic Imaging, 2020
- Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort studyThe Lancet, 2020
- Albumin versus crystalloid solutions in patients with the acute respiratory distress syndrome: a systematic review and meta-analysisCritical Care, 2014
- Acute Respiratory Distress SyndromeJAMA, 2012
- Interleukin-6 Induces Oxidative Stress and Endothelial Dysfunction by Overexpression of the Angiotensin II Type 1 ReceptorCirculation Research, 2004